Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Skye Bioscience, Inc. | Chief Executive Officer, Director | Common Stock | 413K | $4.13M | $10.00 | Aug 26, 2024 | Direct |
Skye Bioscience, Inc. | Chief Executive Officer, Director | Common Stock | 9.34K | $93.4K | $10.00 | Aug 26, 2024 | Trust |
Arch Therapeutics, Inc. | Director | Stock Option (right to buy) | 250K | Nov 10, 2022 | Direct | ||
Skye Bioscience, Inc. | Chief Executive Officer, Director | Stock Option (Right to Buy) | 125K | Feb 29, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
SKYE | Skye Bioscience, Inc. | Aug 26, 2024 | 1 | $0 | 4 | Aug 27, 2024 | Chief Executive Officer, Director |
SKYE | Skye Bioscience, Inc. | Feb 29, 2024 | 2 | $0 | 4/A | Mar 4, 2024 | Chief Executive Officer, Director |
SKYE | Skye Bioscience, Inc. | Feb 29, 2024 | 2 | $0 | 4 | Mar 1, 2024 | Chief Executive Officer, Director |
SKYE | Skye Bioscience, Inc. | Nov 6, 2023 | 2 | $0 | 4 | Nov 6, 2023 | Chief Executive Officer, Director |
SKYE | Skye Bioscience, Inc. | Aug 25, 2023 | 5 | $18.5K | 4/A | Aug 31, 2023 | Chief Executive Officer, Director |
SKYE | Skye Bioscience, Inc. | Nov 10, 2022 | 6 | $0 | 4 | Nov 15, 2022 | Chief Executive Officer, Director |
ARTH | Arch Therapeutics, Inc. | Nov 10, 2022 | 1 | $0 | 4 | Nov 10, 2022 | Director |
SKYE | Skye Bioscience, Inc. | Dec 14, 2021 | 2 | $0 | 4 | Dec 16, 2021 | Chief Executive Officer, Director |
ARTH | Arch Therapeutics, Inc. | Sep 27, 2021 | 2 | $0 | 4 | Oct 1, 2021 | Director |